Literature DB >> 17012230

Context-dependent dysregulation of transcription by mutant huntingtin.

Jonathan Cornett1, Lauren Smith, Meyer Friedman, Ji-Yeon Shin, Xiao-Jiang Li, Shi-Hua Li.   

Abstract

Huntington disease (HD) is an adult-onset neurodegenerative disease caused by expansion of a polyglutamine (poly(Q) tract in the N-terminal region of huntingtin (htt). Although the precise mechanisms leading to neurodegeneration in HD have not been fully elucidated, transcriptional dysregulation has been implicated in disease pathogenesis. In HD, multiple N-terminal mutant htt fragments smaller than the first 500 amino acids have been found to accumulate in the nucleus and adversely affect gene transcription. It is unknown whether different htt fragments in the nucleus can differentially bind transcription factors and affect transcription. Here, we report that shorter N-terminal htt fragments, which are more prone to misfolding and aggregation, are more competent to bind Sp1 and inhibit its activity. These effects can be reversed by Hsp40, a molecular chaperone that reduces the misfolding of mutant htt. Our results provide insight into the beneficial effects of molecular chaperones and suggest that context dependent transcriptional dysregulation may contribute to differential toxicity of various N-terminal htt fragments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17012230     DOI: 10.1074/jbc.M607839200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease.

Authors:  Ignacio Munoz-Sanjuan; Gillian P Bates
Journal:  J Clin Invest       Date:  2011-02-01       Impact factor: 14.808

2.  N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking.

Authors:  Adam L Orr; Shihua Li; Chuan-En Wang; He Li; Jianjun Wang; Juan Rong; Xingshun Xu; Pier Giorgio Mastroberardino; J Timothy Greenamyre; Xiao-Jiang Li
Journal:  J Neurosci       Date:  2008-03-12       Impact factor: 6.167

3.  Mass spectrometric identification of novel lysine acetylation sites in huntingtin.

Authors:  Xin Cong; Jason M Held; Francesco DeGiacomo; Akilah Bonner; Jan Marie Chen; Birgit Schilling; Gregg A Czerwieniec; Bradford W Gibson; Lisa M Ellerby
Journal:  Mol Cell Proteomics       Date:  2011-06-18       Impact factor: 5.911

4.  Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms.

Authors:  Jennifer Bradford; Ji-Yeon Shin; Meredith Roberts; Chuan-En Wang; Xiao-Jiang Li; Shihua Li
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-11       Impact factor: 11.205

5.  Transcriptional dysregulation of TrkA associates with neurodegeneration in spinocerebellar ataxia type 17.

Authors:  Anjali G Shah; Meyer J Friedman; Shanshan Huang; Meredith Roberts; Xiao-Jiang Li; Shihua Li
Journal:  Hum Mol Genet       Date:  2009-07-30       Impact factor: 6.150

6.  ATF3 plays a protective role against toxicity by N-terminal fragment of mutant huntingtin in stable PC12 cell line.

Authors:  Yideng Liang; Haibing Jiang; Tamara Ratovitski; Chunfa Jie; Masayuki Nakamura; Ricky R Hirschhorn; Xiaofang Wang; Wanli W Smith; Tsonwin Hai; Michelle A Poirier; Christopher A Ross
Journal:  Brain Res       Date:  2009-06-24       Impact factor: 3.252

7.  Huntington's Disease: From Mutant Huntingtin Protein to Neurotrophic Factor Therapy.

Authors:  Youssef Sari
Journal:  Int J Biomed Sci       Date:  2011-06

8.  Disruption of zinc transporter ZnT3 transcriptional activity and synaptic vesicular zinc in the brain of Huntington's disease transgenic mouse.

Authors:  Li Niu; Li Li; Shiming Yang; Weixi Wang; Cuifang Ye; He Li
Journal:  Cell Biosci       Date:  2020-09-11       Impact factor: 7.133

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.